Strandberg MC

No ORCID on file · 1 paper in corpus

2024

A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab.

Multiple sclerosis journal - experimental, translational and clinical ·doi:10.1177/20552173241252566

BackgroundFatigue is the most debilitating symptom in patients with multiple sclerosis (MS). Natalizumab and rituximab are the most used MS disease modifying therapies in Sweden, but comparative data on the effect on fatigue is sparse.Objec…